Clinical trial
Prevention of RSV Infections in Bone Marrow Transplant Recipients
NCT00001903 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001903 |
|---|---|
| Title | Prevention of RSV Infections in Bone Marrow Transplant Recipients |
| Official title | Prevention of RSV Infections in Bone Marrow Transplant Recipients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Respiratory Syncytial Virus Infection |
| Intervention type | Drug |
| Interventions | RSV Polyclonal Immunoglobulin |
| Enrollment | 120 |
| Start date | Apr 1, 1999 |
| Completion | May 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: